Lin J - Search Results

1

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.

Saura C, Oliveira M, Feng YH, Dai MS, Chen SW, Hurvitz SA, Kim SB, Moy B, Delaloge S, Gradishar W, Masuda N, Palacova M, Trudeau ME, Mattson J, Yap YS, Hou MF, De Laurentiis M, Yeh YM, Chang HT, Yau T, Wildiers H, Haley B, Fagnani D, Lu YS, Crown J, Lin J, Takahashi M, Takano T, Yamaguchi M, Fujii T, Yao B, Bebchuk J, Keyvanjah K, Bryce R, Brufsky A; NALA Investigators. Saura C, et al. Among authors: lin j. J Clin Oncol. 2020 Sep 20;38(27):3138-3149. doi: 10.1200/JCO.20.00147. Epub 2020 Jul 17. J Clin Oncol. 2020. PMID: 32678716 Free PMC article. Clinical Trial.

2

Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metastatic breast cancer (mBC) previously treated with two or more HER2-directed regimens.

Dai MS, Feng YH, Chen SW, Masuda N, Yau T, Chen ST, Lu YS, Yap YS, Ang PCS, Chu SC, Kwong A, Lee KS, Ow S, Kim SB, Lin J, Chung HC, Ngan R, Kok VC, Rau KM, Sangai T, Ng TY, Tseng LM, Bryce R, Bebchuk J, Chen MC, Hou MF. Dai MS, et al. Among authors: lin j. Breast Cancer Res Treat. 2021 Oct;189(3):665-676. doi: 10.1007/s10549-021-06313-5. Epub 2021 Sep 23. Breast Cancer Res Treat. 2021. PMID: 34553296 Free PMC article. Clinical Trial.

3

Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers. An effective and low-toxic regimen for patients with poor general condition.

Hsu CH, Yeh KH, Chen LT, Liu JM, Jan CM, Lin JT, Chen YC, Cheng AL. Hsu CH, et al. Among authors: lin jt. Oncology. 1997 Jul-Aug;54(4):275-80. doi: 10.1159/000227702. Oncology. 1997. PMID: 9216850 Clinical Trial.

4

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial.

Chen MH, Lin J, Hsiao CF, Shan YS, Chen YC, Chen LT, Liu TW, Li CP, Chao Y. Chen MH, et al. Among authors: lin j. Medicine (Baltimore). 2016 Jan;95(3):e2565. doi: 10.1097/MD.0000000000002565. Medicine (Baltimore). 2016. PMID: 26817912 Free PMC article. Clinical Trial.

5

Upfront maintenance therapy with arsenic trioxide in acute promyelocytic leukemia provides no benefit for non-t(15;17) subtype.

Chiang YH, Chang YF, Hsieh RK, Lin J, Chen CG, Lim KH, Lin HC, Chang MC. Chiang YH, et al. Among authors: lin j, lin hc. Asia Pac J Clin Oncol. 2012 Dec;8(4):330-6. doi: 10.1111/j.1743-7563.2011.01496.x. Epub 2012 Mar 12. Asia Pac J Clin Oncol. 2012. PMID: 22897350

6

Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.

Chen LT, Lin JT, Shyu RY, Jan CM, Chen CL, Chiang IP, Liu SM, Su IJ, Cheng AL. Chen LT, et al. Among authors: lin jt. J Clin Oncol. 2001 Nov 15;19(22):4245-51. doi: 10.1200/JCO.2001.19.22.4245. J Clin Oncol. 2001. PMID: 11709568

7

A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study.

Su YY, Chiu YF, Li CP, Yang SH, Lin J, Lin SJ, Chang PY, Chiang NJ, Shan YS, Ch'ang HJ, Chen LT. Su YY, et al. Among authors: lin sj, lin j. Br J Cancer. 2022 Apr;126(7):1018-1026. doi: 10.1038/s41416-021-01649-7. Epub 2021 Dec 17. Br J Cancer. 2022. PMID: 34921230 Free PMC article. Clinical Trial.

8

Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.

Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL. Hsu CH, et al. Among authors: lin jt. Anticancer Res. 1999 Sep-Oct;19(5C):4463-7. Anticancer Res. 1999. PMID: 10650793

9

Five-drug combination chemotherapy (FAPEL) for advanced gastric cancer: a pilot study.

Yeh KH, Cheng AL, Chen YC, Chen BR, Lee WJ, Lin JT, Lee PH, Chang KJ, Wang CH, Wang TH. Yeh KH, et al. Among authors: lin jt. J Formos Med Assoc. 1994 Jan;93(1):20-4. J Formos Med Assoc. 1994. PMID: 7915575

10

Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.

Cheng AL, Yeh KH, Lin JT, Hsu C, Liu MY. Cheng AL, et al. Among authors: lin jt. Anticancer Res. 1998 Mar-Apr;18(2B):1267-72. Anticancer Res. 1998. PMID: 9615799 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38,471 results

Search Page